PRKAA1 and breast cancer: As shown in a breast cancer cell line, metformin reduced the expression of miR-21 and enhanced the expression of critical upstream activators of the AMPK including sestrin 1, leading to AMPK activation and inhibition of mTORC1 signaling [540].